Dalton Inc.

Company News

Dalton Pharma Services Announces Completion of its GMP Oligonucleotide Manufacturing Facility

TORONTO, April 12 /PRNewswire/ -- Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider to leading pharmaceutical companies, today announced the completion of its state-of-art Oligonucleotide Production Suite. Large-scale DNA and RNA oligonucleotide synthesis has now gained industry importance with proven therapeutic and diagnostic applications. Building on our 17...

Read More »

All Topics